Corvus Pharmaceuticals (CRVS) Receivables (2022 - 2026)
Corvus Pharmaceuticals (CRVS) reported Receivables of $6,000 for Q2 2026, down 93.0% from $86,000 a year earlier and down 86.0% from the prior quarter.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Receivables (2022 - 2026) Analysis & Trends
At the end of FY2025, Corvus Pharmaceuticals posted Receivables of $37,000, down 50.7% from FY2024.
- Receivables has a three-year compound annual growth rate of -68.4% (FY2022 to FY2025).
- By year, Receivables came in at $75,000 in FY2024 (+44.2%), $52,000 in FY2023 (-95.6%) and $1.18 million in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Receivables in data going back to Q4 2022.
- Year over year, Receivables has now declined in each of the last four quarters, with an average decline of 21.1% over the last seven quarters.
- The high point for year-over-year Receivables in five years was Q1 2025 (growth of 51.9%); the low point was Q4 2023 (a decline of 95.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $43,000 (Q1 2026), $37,000 (Q4 2025) and $32,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Corvus Pharmaceuticals | 998.52 Mn | 486.96 Mn | - | 6,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,000.00 |
| Mar 31, 2026 | 43,000.00 |
| Dec 31, 2025 | 37,000.00 |
| Sep 30, 2025 | 32,000.00 |
| Jun 30, 2025 | 86,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Dec 31, 2024 | 75,000.00 |
| Sep 30, 2024 | 140,000.00 |
| Jun 30, 2024 | 70,000.00 |
| Mar 31, 2024 | 52,000.00 |
| Dec 31, 2023 | 52,000.00 |
| Sep 30, 2023 | 11,000.00 |
| Dec 31, 2022 | 1.18 Mn |
API Access
Corvus Pharmaceuticals Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();